This research-based course has a taught component that is the same as an MSc. It provides a springboard into a career that involves a working knowledge of scientific research.
The course is designed for graduates with a BSc in the life sciences or other science disciplines, and for intercalating and fully qualified MBBS or BDS students. It can be taken either as a stand-alone qualification or as an entry route onto a PhD or MD.
The taught component of the course includes subject-specific content in the area of translational medicine and therapeutics. You have the flexibility to develop your own bespoke course by selecting additional, complementary modules. You will also participate in training in general research principles, and other professional and key skills.
Subject-based modules in translational medicine and therapeutics provide the opportunity to learn about the development and evaluation of new medicines and to develop skills in translational research relating to therapeutics. Teaching and supervision is provided by both university-based academics and experts from the pharmaceutical industry.
Your research project comprises the major element of the course. This project will involve 24 weeks of research in an area of translational medicine and therapeutics under the supervision of an expert academic researcher in the field.
The course allows you to experience an internationally competitive research area, predominantly in academia but also potentially in industry.
Translational Medicine and Therapeutics MRes is closely linked to a suite of MRes courses that you may also be interested in:
Our Medical Sciences Graduate School is dedicated to providing you with information, support and advice throughout your research degree studies. We can help and advise you on a variety of queries relating to your studies, funding or welfare.
Our Research Student Development Programme supports and complements your research whilst developing your professional skills and confidence.
You will make an on-going assessment of your own development and training needs through personal development planning (PDP) in the ePortfolio system. Our organised external events and development programme have been mapped against the Vitae Researcher Development Framework to help you identify how best to meet your training and development needs.
Translational research in medicine is an exciting and rapidly developing interdisciplinary field. It focuses on taking new research findings from the laboratory and other research contexts, and using them to develop effective advances in healthcare as quickly and efficiently as possible.
Our Translational Medicine modules are ideal for people with a relevant undergraduate degree who want to train for a career in translational research or related fields, for medical students who want to obtain a postgraduate degree during an intercalated year, and for clinicians and other professionals who want to develop their expertise.
The MRes Translational Medicine will help you develop into a confident and self-reliant researcher who is skilled at self-directed learning, laboratory investigation, data analysis and scientific communication.
You will have the opportunity to contribute to a translational research programme, develop an advanced understanding of the fundamentals of genetics and genomics, study the principal stages in the development of novel therapeutics, learn about technologies used in biomedical/translational research, and acquire hands-on data analysis skills.
The programme has been designed with input from the pharmaceutical/biotechnology industry and will equip you with an expert understanding of the relevant bioscience, ‘bench-to-bedside’ development pathways and with the technical knowledge that will prepare you to progress to a PhD-level programme or to participate in research and development of a pharmaceutical/biotechnology setting.
Our Master of Research (MRes) in Translational Medicine will give you the research skills you need to use state-of-the-art biotechnologies to rapidly translate disease research into improved clinical healthcare.
Our understanding of the molecular basis of disease and drug mechanisms has improved dramatically in recent years, yet there is a distinct shortage of individuals able to apply this knowledge into effective clinical benefit. The core aim is to train the next generation of scientists able to 'fast-track' biological and scientific data into advanced therapies and diagnostics tools.
With advances in technology, graduates are faced with heightened expectations to conduct effective bioscience research. Employers demand skillsets with biological, medical, physical and computational characteristics, and our course is designed to provide this breadth of training.
You will learn omics skills and techniques such as genetics, genomics, transcriptomics, proteomics and metabolomics. Our training in metabolomic techniques is novel for a UK course, while our teaching on the integration of different omic platforms and data in a systems medicine strategy is also unique.
The MRes course consists of four taught units - which together make up the PGCert - plus an extended 35-week project that can be undertaken at the University, the Manchester Cancer Research Centre or a teaching hospital in Greater Manchester.
You can choose from a range of projects covering areas such as the use of gene expression profiling, proteomics, metabolomics, stem cell research, tissue culture or pharmacogenetics in the biology of cancer, cardiovascular disease, infectious diseases, stroke or diabetes.
Completing our course will open up a route into PhD research. You may also pursue a career in academia or the pharmaceutical or biotechnology industries, or as a clinical academic.
Extensive research experience
The 35-week research project for the MRes award offers the chance to conduct ambitious projects in areas such as cancer, cardiovascular disease, inflammation, mental health, infectious diseases, stroke or diabetes, using methods such as stem cell research, proteomics, metabolomics, tissue culture or pharmacogenetics.
Integrated focus on key topics
Our course has a strong and integrated focus on genetics, genomics, proteomics and metabolomics biotechnology and data interpretation, which are strengths within Manchester and are identified as core areas of bioscience growth.
Teaching comprises four taught units delivered using a variety of face-to-face, workshop and e-learning approaches and an extended 35-week research project for the MRes award.
Examples of research projects include the following.
Find out more by visiting the postgraduate teaching and learning page.
More than 50% of our graduates progress into PhD research at Manchester or other universities such as Cambridge, Imperial College London, Newcastle, Glasgow, Liverpool and Bristol.
Around 15% pursue a career in the pharmaceutical or biotechnology industry in the UK or abroad.
Approximately 25% are intercalating medics who complete their medical education. An estimated 10% pursue an undergraduate medical degree.
Upon graduation, the student is expected
Further information about the studies on the Master's programme website.
The TRANSMED studies are built upon three themes:
Development of research skills
The curriculum includes courses in statistics and the R programming language, bioinformatics, research ethics, and principles of clinical investigation. You will also practice the writing of research proposals and develop your skills in research methodologies during a training period in a research group.
Studies in human disease
The courses range from normal human physiology and anatomy, and basic biomedical courses, to more advanced studies covering topics pertinent to the specialist option. You supplement these studies with clinical rounds, during which you have the opportunity to study selected patient cases in hospital wards, under the supervision of a clinician mentor.
Development of communication skills
Communication skills are promoted through interactive approaches and discussions, groupwork, team-based learning and oral presentations. In TRANSMED you will have opportunities for direct interactions with medical students, scientists and clinical teachers to enable you to practice and adopt interdisciplinary communication skills. At the end of the course of study, your communication skills will be evaluated in a Research Proposal Exam, during which you will orally present and defend your research plan to expert examiners.
The aim of this programme is to train a new generation of physicians and scientists able to successfully transfer neuroscience and pharmacology discoveries from the bench to the bedside. The course emphasizes a true translational approach by teaching basic science in an academic environment, involving you in current research techniques and also offering the opportunity to meet patients suffering from a range of neurological diseases.
The topics covered range from the principles of drug design and development to clinical aspects of the management of major neurological diseases, thus providing specialised training and essential skills for translational research. The clinical component is unique to this course and ties together the scientific, clinical and personal aspects of neurological disease.
The MSc in Experimental Medicine offers advanced research training in a broad range of laboratory based biomedical sciences.
MSc in Experimental Medicine is designed for students wishing to pursue a career in experimental medicine, whether it is in academia, clinical practice, industry or government. The programme will also provide an excellent platform for progression to PhD programmes either in Queen’s or worldwide.
MSc in Experimental Medicine will develop a strong fundamental understanding of high quality biomedical research, including experimental design and execution, data management and interpretation, and scientific communication, including publishing, presentation, and use of social media.
The programme offers comprehensive research training with access to over 40 research groups and the state-of-the-art research facilities at the Centre for Experimental Medicine (CEM). Research facilities include Central Technology Units for Imaging and Genomics which are leading the way in research excellence and innovative healthcare.
Experimental medicine aims to identify mechanisms of pathophysiology of disease, and demonstrate proof-of-concept evidence of the efficacy and importance of new discoveries or treatments. There is an increasing need for graduates who can undertake basic and clinical research, and translate it into improved medical treatments for patients.
This research-intensive MSc programme in Experimental Medicine will equip you with the rigorous research skills, and the innovative mentality to tackle the major medical and therapeutic challenges of the 21st century.
For further information email [email protected] or send us a message on WhatsApp
The strong links between the Centre for Experimental Medicine and the biotech or biopharmaceutical sectors provides a stimulating experimental and translational environment, while also expanding your career opportunities.
PROFESSIONAL ACCREDITATIONS
WORLD CLASS FACILITIES
STUDENT EXPERIENCE
Semester 1
It comprises 3 months of intensive teaching, which includes essential research skills followed by specialist chosen modules entitled “Infection & Immunity”, or “Diabetes and Cardiovascular Disease”. The remaining period will provide a unique opportunity to focus for 8 months on an extensive research project chosen from a large panel of projects offered by Principal Investigators in the CEM in one of the above themes. This period will be interspersed with monthly training to develop project-specific transferable skills, such as oral and poster presentation, and scientific writing.Semester 2
Semester 2
You will specialise in one of these two research streams:
RESEARCH PROJECT
You’ll undertake a project at the Centre of Experimental Medicine, QUB, relating to the research stream that you have chosen.
For further information email [email protected] or send us a message on WhatsApp
You will develop advanced knowledge in all aspects of precision medicine including genomics, bioinformatics, structural biology, genetics and epigenetics of disease and their precision diagnosis and treatment, biomedical imaging techniques, nanomedicines; generation and analysis of big data. You will gain awareness of the context in which precision medicine is being applied in healthcare, research and industry. You will also develop a range of intellectual, practical and transferable skills essential for a career in this field.
Students undertake modules to the value of 180 credits.
A Postgraduate Diploma (120 credits) is also offered.
A Postgraduate Certificate (60 credits) is also offered.
The programme consists of four core modules (60 credits), four optional modules (60 credits) and a research project (60 credits).
Select four optional modules.
All MSc students undertake an independent research project which can take the form of a wet lab/computer modelling based project or a literature project.
The programme is delivered through a combination of lectures, tutorials, self study, practical sessions and discussion groups. The research project forms one third of the programme. Each of the taught modules is assessed by unseen written examination (50%) and coursework (50%). The research project is assessed by the dissertation and viva.
Further information on modules and degree structure is available on the department website: Precision Medicine MSc
For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
The MSc will provide an excellent background for those looking to establish a career in biotech, pharma, national research laboratories and NHS agencies. The knowledge and transferable skills delivered will also be useful for those who intend to pursue academic research or medical studies.
UCL, in partnership with UCL Hospitals, is an internationally renowned and productive centre with established strengths in translating pioneering scientific research into tangible treatments. The results of REF2014 show that UCL enjoys the greatest amount of “world leading” (4*) research in Medicine and Biological sciences. This was a tremendous achievement for the Division of Medicine, which led the return in Clinical Medicine for UCL. In Clinical Medicine, UCL was ranked first in the UK (according to Research Fortnight's Power Rankings), a testament to our research strength in the Division of Medicine.
The UCL Division of Medicine has significiant expertise in the field of precision medicine. The division has pioneered multidisciplinary research and successfully translated innovative research into useful clinical benefit. Students on the MSc will have the opportunity to interact and conduct research with leading groups in the field.
The UCL Division of Medicine research expertise includes: inflammation, internal medicine, metabolism, nephrology, respiratory, liver and digestive health, medicinal chemistry, computational drug design, neuronal development and signalling, cell cycle control, intensive care medicine, regenerative medicine, tissue engineering, nanomedicine, stem cells, mitochondrial biology and cancer.
Department: Division of Medicine
Student / staff numbers › 411 staff including 84 postdocs › 133 taught students › 193 research students
Staff/student numbers information correct as of 1 August 2017.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Application fee: There is an application processing fee for this programme of £75 for online applications and £100 for paper applications. More details about the application fee can be found at http://www.ucl.ac.uk/prospective-students/graduate/taught/application.
This MSc is primarily suitable for life science or medical science graduates. Students with an interest in precision medicine who have a background in biological sciences, chemical sciences, physics, mathematics or pharmacy may also be eligible to apply.
When we assess your application we would like to learn:
Together with essential academic requirements, the personal statement is your opportunity to illustrate whether your reasons for applying to this programme match what the programme will deliver.
All applicants
27 July 2018
For more information see our Applications
Apply Now: http://www.ucl.ac.uk/prospective-students/graduate/apply
This online programme will give you a comprehensive understanding of the processes, investigation procedures and treatment options for common diseases you encounter in general medical practice.
The programme is mostly for early postgraduate doctors. It complements the learning you need to achieve membership of the Royal College of Physicians and it may also be suitable for doctors in other specialties, or nurse consultants and other paramedical specialists with extensive clinical experience.
We cover basic physiology, pathophysiology, therapy and clinical management, as well as clinical skills, generic skills (including writing and research methods) law, ethics and prescribing ability.
Problem-based learning through clinical case scenarios will be used to enhance knowledge and clinical decision-making. We use a variety of e-learning resources and platforms, including a virtual classroom with online tutorials and lectures, online interactive resources and virtual patients.
Our online learning technology is fully interactive, award-winning and enables you to communicate with our highly qualified teaching staff from the comfort of your own home or workplace. Students not only have access to Edinburgh’s excellent resources, but also become part of a supportive online community, bringing together students and tutors from around the world.
This programme is made up of compulsory and optional courses.
Compulsory courses
Optional courses
Further programme information
This programme is designed to help medical professionals gain the next step in their medical career, with a highly regarded qualification and first-rate expertise.
Translational Cancer Medicine enables you to gain detailed knowledge and understanding of research methods applied to rational drug design, clinical study design, molecular and cell biology, tumour immunology, genetics and cancer imaging. You'll gain practical experience through two six-month laboratory rotations.
The Translational Cancer Medicine MRes study pathway offers unique opportunities for you to join experienced research teams and work on particular projects from the outset. This course will allow you to develop an in-depth understanding of research methods, and of how theoretical academic studies and skills relate to research projects.
You will explore Fundamentals of Translational Cancer Medicine, providing you with advanced knowledge and skills to conceptualise, design, conduct and critically appraise specialist research. You will gain hands on research experience in two six month lab projects.
Teaching
We use lectures, seminars and group meetings to deliver most of the modules on the course.
On average teaching consists of:
You will also be expected to undertake a significant amount of independent study.
Typically, 1 credit equates to ten hours of work.
Throughout the year, you will also attend literature reviews and journal clubs that the labs/departments organise, as well as any other internal or external seminars deemed relevant to your projects/assignments.
Assessment
The primary method of assessment for this course is a combination of written essays, a thesis (research report), a presentation/Q&A session regarding the research report and a draft of a scientific paper.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they are subject to change.
Occupational health clearance will be required for some of the projects.
Future PhD studies. Clinical and non-clinical academic careers in cancer medicine.
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.
You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.
Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.
Extensive practical experience
You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.
Meet the course team
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.
Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.
Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.
Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.
He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.
Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.
Taught course units will predominantly use lectures and workshops.
For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.
The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.
You will be assessed through oral presentations, single best answer exams, written reports and dissertation.
For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.
Research proposal
Publication-based/dissertation by publication
Service development/professional report/ report based dissertation
Adapted systematic review (qualitative data)
Full systematic review that includes data collection (quantitative data)
Qualitative or quantitative empirical research
Qualitative secondary data analysis/analysis of existing quantitative data
Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review
Teaching will take place within The Christie NHS Foundation Trust , Withington.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: [email protected]
This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.
The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.
The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.
